BTA 0.00% 57.0¢ biota holdings limited

facts speak louders than catchcries bohoohoo, page-2

  1. 757 Posts.
    There you have it, indeed.

    By the way did you know GSK is considering repackaging Relenza as a shot or nebulizer to increase sales?



    They started "considering" in 2005*. I wonder if they've reached any conclusions yet. So much "best effort", I agree with Peter Cook, our lawsuit never stood a chance.

    *http://www.zdnetasia.com/blogs/bcp/0,3800011228,39377583,00.htm
    Original article in "Nature Medicine" is still pay per view.
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.